FNH Does Not Cause Elevated CEA of 199 ng/mL
Focal nodular hyperplasia (FNH) is a benign liver lesion that does not produce elevated serum CEA levels; a CEA of 199 ng/mL strongly suggests metastatic adenocarcinoma, most likely from a gastrointestinal primary source, and requires urgent investigation for malignancy.
Why FNH Cannot Explain This CEA Level
FNH is the second most common benign liver lesion and is characterized by mature hepatocytes, fibrous septae, and ductular reaction 1, 2. While one case report documented CEA expression within the ductular reaction cells of FNH tissue on immunohistochemistry 3, this represents intracellular staining only and does not translate to elevated serum CEA levels. The hepatocytes in FNH are negative for CEA 3.
What a CEA of 199 ng/mL Actually Indicates
A serum CEA of 199 ng/mL is profoundly elevated and highly suspicious for malignancy:
- Normal CEA range: <5 ng/mL in most laboratories 4
- CEA levels of 591-672 ng/mL are seen in metastatic adenocarcinoma from colon, stomach, and pancreas 5
- Your level of 199 ng/mL falls well within the range typical of metastatic gastrointestinal adenocarcinoma
The ASCO guidelines confirm that CEA is the marker of choice for monitoring metastatic colorectal cancer, with persistently rising values suggesting progressive disease 4.
Critical Diagnostic Algorithm
Immediate next steps:
Obtain detailed history for:
- Prior or current gastrointestinal symptoms (change in bowel habits, rectal bleeding, abdominal pain)
- Weight loss, anorexia
- Personal or family history of colorectal, gastric, or pancreatic cancer
Perform colonoscopy - CEA levels this high with a liver lesion mandate evaluation for colorectal primary
Order CT chest/abdomen/pelvis with contrast - to identify primary tumor and assess for other metastases
Consider upper endoscopy and/or pancreatic protocol CT if colonoscopy is negative
Liver biopsy of the lesion may be necessary if imaging is equivocal, as fine-needle aspirate CEA content can exceed serum values by 10-100 fold and help confirm metastatic adenocarcinoma 5
Important Caveats
Non-malignant causes of elevated CEA include gastritis, peptic ulcer disease, diverticulitis, liver diseases, COPD, and diabetes 4. However, these conditions typically cause modest elevations, not levels approaching 200 ng/mL.
Extremely rare consideration: While FNH combined with hepatocellular carcinoma has been reported in exceptional cases 6, 7, HCC does not typically elevate CEA. One case showed FNH with clonal progression to HCC 7, but this represents malignant transformation, not FNH itself causing CEA elevation.
The Bottom Line
Do not attribute a CEA of 199 ng/mL to FNH. This represents either:
- Metastatic adenocarcinoma to the liver (most likely GI primary) with coincidental FNH
- Misdiagnosis of the liver lesion (it's actually metastatic disease, not FNH)
The ACR Appropriateness Criteria emphasize that benign lesions can be found in nearly 30% of patients with primary malignancy 1, meaning FNH and metastatic disease can coexist. Pursue aggressive workup for occult malignancy immediately.